These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 347787)

  • 21. Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats.
    Schmidt W; Jähnchen E
    J Pharm Pharmacol; 1977 May; 29(5):266-71. PubMed ID: 17688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics and clinical importance of the interactions of rifampicin with phenprocoumone and isoniazide].
    von Oldershausen HF; Musch E; Rudolf G; Gieraths A; Schunter C
    Verh Dtsch Ges Inn Med; 1978; (84):1468-72. PubMed ID: 741993
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of phenprocoumon intoxication with cholestyramine.
    Meinertz T; Gilfrich MJ; Bork R; Jahnchen E
    Br Med J; 1977 Aug; 2(6084):439. PubMed ID: 890329
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of (+)-Catechin and Dithiocarb on the Pharmacokinetics of Phenprocoumon, Tolbutamide and Three Inhalation Anesthetics in rats].
    Siegers CP; Iven H
    Arzneimittelforschung; 1982; 32(11):1437-40. PubMed ID: 6295415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The influence of diazepam (valium) on the effect of phenprocoumon (marcumar) (author's transl)].
    Schunter C; Held H; Schmülling R
    Klin Wochenschr; 1978 Mar; 56(6):305-7. PubMed ID: 642402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of naproxen on the thrombocyte bleeding time and on the anticoagulant treatment with phenprocoumon].
    Angelkort B
    Fortschr Med; 1978 Jun; 96(23):1249-52. PubMed ID: 658877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigations into the binding of phenprocoumon to albumin using fluorescence spectroscopy.
    Otagiri M; Fleitman JS; Perrin JH
    J Pharm Pharmacol; 1980 Jul; 32(7):478-82. PubMed ID: 6105183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of guar an phenprocoumon concentration in serum and on coagulation reaction parameters of orally administered phenprocoumon].
    Kasper H; Barthel S; Feldmann K; Trobisch H; Schrezenmeir J
    Beitr Infusionther Klin Ernahr; 1983; 12():56-60. PubMed ID: 6316918
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.
    Spahn H; Kirch W; Mutschler E; Ohnhaus EE; Kitteringham NR; Lögering HJ; Paar D
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):97S-102S. PubMed ID: 6743480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the interaction of Phenprocoumon with Diazepam and with Nitrazepam (author's transl)].
    Kinawi A; Teller C
    J Clin Chem Clin Biochem; 1978 May; 16(5):313-4. PubMed ID: 670897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral anticoagulant treatment; which anticoagulant?].
    Thijssen HH; Hemker HC
    Ned Tijdschr Geneeskd; 1984 Aug; 128(33):1559-63. PubMed ID: 6483024
    [No Abstract]   [Full Text] [Related]  

  • 32. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.
    Caldwell JH; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD; Toon S; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):312-9. PubMed ID: 3621786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interaction of rifampicin with phenprocoumon (author's transl)].
    Held H
    Dtsch Med Wochenschr; 1979 Sep; 104(37):1311-4. PubMed ID: 477551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.
    Ohnhaus EE; Berger W; Duckert F; Oesch F
    Klin Wochenschr; 1983 Sep; 61(17):851-8. PubMed ID: 6632727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on possible interactions between tiaprofenic acid and phenprocoumon (author's transl)].
    Dürr J; Pfeiffer MH; Penth B; Wetzelsberger K; Lücker PW
    Arzneimittelforschung; 1981; 31(12):2163-7. PubMed ID: 7199320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the interactions of phenprocoumon with chlordiazepoxide in rats (author's transl)].
    Kinawi A; Baumgartl I
    J Clin Chem Clin Biochem; 1977 Aug; 15(8):425-9. PubMed ID: 915441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
    Harenberg J; Haas R; Zimmermann R
    Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
    O'Reilly RA
    Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9.
    He M; Korzekwa KR; Jones JP; Rettie AE; Trager WF
    Arch Biochem Biophys; 1999 Dec; 372(1):16-28. PubMed ID: 10562412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.